This video reviews the need for biomarkers and tools that could identify those at high risk of immune-related toxicities among patients undergoing immunotherapy treatment.
In this video, Vamsidhar Velcheti, MD, of the Cleveland Clinic in Cleveland, Ohio, discusses the need for tools and biomarkers to identify those at high risk of immune-related toxicities among patients undergoing immunotherapy treatment, and reviews some of the dangerous toxicities that can occur.
Velcheti gave a presentation on this topic earlier this year during an education session at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.
Eric Ko on Combining Radiation Therapy With Immunotherapy to Treat Non–Small-Cell Lung Cancer
September 18th 2018ONCOLOGY spoke with Eric Ko, MD, PhD, who recently published a review article with his colleagues on strategies for combining radiation therapy with immunotherapy for the treatment of non–small-cell lung cancer.
2 Clarke Drive
Cranbury, NJ 08512